Myeloid neoplasm with both dysplastic and myeloproliferative features, which does not show specific disease-defining cytogenetic abnormalities and does not now or on previous biopsies satisfy criteria of a defined myeloid neoplasm
Myelodysplastic and myeloproliferative features are BOTH REQUIRED
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, World Health Organization Classification of Tumours 2008
Hall J, Foucar K, Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders, International Journal of Laboratory Hematology, 2010, 32
Orazi A, Germing U. (2008) The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia, 22, 1308–1319.
Kanagal-Shamanna R et al, Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/ myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer. 2011 Oct 28. doi: 10.1002/cncr.26537. [Epub ahead of print]